No profile data available.
Lensar, Inc. (LNSR) is a healthcare company in the targeted healthcare equipment industry, based in Orlando, United States, with about 150 full-time employees.
It reported revenue of $58.44 million for fiscal year 2025, up 9.2% from fiscal year 2024, and net income of -$34.28 million. United States was its largest region in fiscal year 2025, with 66% of revenue. Its market capitalization was $78.26 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally.
Lensar reported $58.44 million in revenue for fiscal year 2025, up 9.2% from $53.49 million in fiscal year 2024.
United States: 66% of revenue by region in fiscal year 2025, followed by Europe (16%).
$78.26 million as of October 9, 2026.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include electroCore, Inc. (ECOR), NeurAxis, Inc. (NRXS), Outset Medical, Inc. (OM), Pulmonx Corporation (LUNG).